CClinicalTrials.gg
CompletedNCT07721337Updated Jul 23, 2026

Periodontitis Severity and Associated Factors Among Egyptian Males and Females

An observational study in Periodontitis, sponsored by Al-Azhar University. Completed at 1 site in Egypt. Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-23.

Sponsored by Al-Azhar University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
380
Ages
20 Years to 40 Years
Sex
All
01

Study summary

This cross-sectional study aims to evaluate and compare the severity of periodontitis between a group of Egyptian males and females. Additionally, the study explores the association between periodontitis severity and various lifestyle and systemic factors, including oral hygiene habits, dietary patterns (vegetable and fruit intake), and Body Mass Index (BMI).

A total of 380 participants (equal numbers of males and females) are examined to determine their periodontitis stage according to the 2017 AAP/EFP classification. Participants also complete a comprehensive questionnaire assessing their daily habits and physical measurements. The findings of this study will help understand gender-based differences in periodontitis severity and identify potential lifestyle risk factors in the Egyptian population.

02

Conditions studied

  • Periodontitis

Browse trials for

03

In context

Periodontitis

1,635 studies on the registry are indexed under Periodontitis; 327 are open to participants now.

This study's enrollment of 380 is above the median of 89 across 427 observational studies indexed under Periodontitis.

Browse Periodontitis studies →

Lead sponsor

Al-Azhar University is the lead sponsor of 505 studies on the registry; 167 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population consists of Egyptian male and female patients visiting the outpatient clinics of the Faculty of Dental Medicine, Al-Azhar University and patients in great Cairo ( Cairo , Giza , Qalyoubia ) who meet the inclusion and exclusion criteria.

Inclusion criteria

  • The inclusion criteria are:

    1. Patients with periodontitis.
    2. Age range from 20 to 40 years.
    3. Patients who are systemically healthy (i.e., without any systemic disease or immune disorders)

Exclusion criteria

Exclusion Criteria:

  • 1. Patients with systemic diseases. 2. Pregnant or lactating females.
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
380 participants (actual)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Egyptian Males

    Egyptian male patients diagnosed with different stages of periodontitis who completed the study questionnaire and underwent clinical periodontal examination

    Other: Clinical Periodontal Examination and Questionnaire

  • Egyptian Females

    Egyptian female patients diagnosed with different stages of periodontitis who completed the study questionnaire and underwent clinical periodontal examination

    Other: Clinical Periodontal Examination and Questionnaire

Interventions

  • OtherClinical Periodontal Examination and Questionnaire

    This is an observational study. The intervention consists of a one-time comprehensive clinical periodontal examination to determine the periodontitis stage (according to AAP/EFP 2017 guidelines) and a detailed lifestyle questionnaire completed by the participants. No therapeutic interventions or new treatments are administered.

06

What researchers measure

Primary outcomes

  1. Severity of Periodontitis

    Periodontitis severity will be assessed clinical examination to determine the stage of periodontitis (Stage I to IV) according to the 2017 AAP/EFP World Workshop classification criteria.

    Time frame: At the time of clinical examination (Day 1)

07

Study locations

1 site
  • Faculty of Dental Medicine, Al-Azhar University
    Cairo, Egypt
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared to maintain participant confidentiality and comply with the institutional ethical committee regulations. The aggregated statistical results and findings of the study will be fully available within the published manuscript.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07721337
Lead sponsor
Al-Azhar University
Responsible party
Nouranne Mohamed Ebrahim El Gabrouny (Master's Candidate, Department of Periodontology, Faculty of Dental Medicine, Al-Azhar University, Al-Azhar University) — Principal investigator
First posted
Jul 23, 2026
Start date
May 1, 2025
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026
Last update
Jul 23, 2026

Study contacts

Noura Abdel Rahman, PhD
study chair · Faculty of Dental Medicine, Al-Azhar University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion